Consequently, CML USP18-deficient cells are more antigenic, driving increased activation of cytotoxic T lymphocytes (CTLs) and are more susceptible to irradiation. This evidence concerns the gene USP18 and chronic myelogenous leukemia, BCR-ABL1 positive.